ClinicalTrials.gg
Not yet recruitingNCT06593470MINDS-UPUpdated Sep 25, 2026

Mindfulness-Based Substance Use Prevention (MINDS-UP)

An interventional study of MINDS-UP and Prevention Plus Wellness in Substance Use, sponsored by New York State Psychiatric Institute. Not yet recruiting. Open to participants aged 10 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Prevention

Updated Sep 25, 2026Enrollment updatedEligibility revised+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
10 Years to 14 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The aims of the study are:

Aim 1: Determine feasibility and acceptability of MINDS-UP as a preventive intervention via a) retention, b) attendance, c) teacher-rated participation, d) student-rated participation, e) homework completion, and f) acceptability.

Aim 2: Evaluate neuropsychological mechanisms (target engagement) of MINDS-UP.

Aim 3 (Exploratory): Assess preliminary efficacy of MINDS-UP on substance use initiation (SUI).

02

Conditions studied

  • Substance Use
03

In context

Substance-Related Disorders

2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.

This study's planned enrollment of 40 is below the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 435 studies on the registry; 27 are open to participants now.

Of its 51 completed or terminated interventional studies of FDA-regulated products, 45 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Sep 25, 2026. See what changed

Ages eligible
10 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
  2. Youth has access to a smartphone, tablet, or computer with Wi-Fi
  3. Youth and parent are English-speaking

Exclusion criteria

Exclusion Criteria:

1. The youth has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Sport: Prevention Plus Wellness (PPW)

    Sport: Prevention Plus Wellness (PPW) is a brief, evidence-based substance use prevention program for youth. PPW consists of a single self-administered 45-minute session that is interactive and intended for use by youth in the home setting. It involves screening youth to increase awareness of their current health behaviors; motivational enhancement for change; and establishing a behavior goal plan.

    Behavioral: Prevention Plus Wellness

  • Experimental
    PPW + MINDS-UP

    MINDS-UP consists of 4 x 60-minute sessions, once weekly over 4 weeks. MINDS-UP will be delivered to participants remotely, in a 1:1 setting, taught by the meditation teachers that will be hired and trained by Dr. Saunders. Additionally, participants will be provided audio files of 5-10-minute guided meditation practices, led by Dr. Saunders, as homework. Participants randomized to MINDS-UP will also complete PPW, a 45 minute, self-administered course.

    Behavioral: MINDS-UP · Behavioral: Prevention Plus Wellness

Interventions

  • BehavioralMINDS-UP

    MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.

  • BehavioralPrevention Plus Wellness

    PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.

    Also known as: PPW

06

What researchers measure

Primary outcomes

  1. Retention

    Percent of participants who completed all study procedures among those who were randomized

    Time frame: Completion of Study (up to 36 months)

  2. Attendance

    Percent of scheduled sessions that were completed by the participant.

    Time frame: Completion of Study (up to 36 months)

  3. Teacher Rated Participation

    Research Assessment Package for Schools - Teacher Rated

    Time frame: Completion of Study (up to 36 months)

  4. Student-Rated Participation

    Research Assessment Package for Schools - Student Engagement

    Time frame: Completion of Study (up to 36 months)

  5. Homework Completion

    Percentage of assigned homeworks that were completed by the participant.

    Time frame: Completion of Study (up to 36 months)

  6. Acceptability

    Acceptability of Intervention Measure

    Time frame: Completion of Study (up to 36 months)

Secondary outcomes

  1. Total Problems (parent-report)

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems

    Time frame: 4-8 weeks, 6 months, and 12 months

  2. ADHD Symptoms

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the ADHD Rating Scale, an 18-item parent-report assessment that measures adolescent behaviors related to ADHD (inattentiveness, hyperactivity).

    Time frame: 4-6 weeks, 6 months, and 12 months

  3. Suicidal Thoughts/Behaviors

    The C-SSRS is a gold-standard assessment tool for suicide risk. This tool will be administered at every visit.

    Time frame: 4-6 weeks, 6 months, 12 months

  4. Alcohol sipping

    Low-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip.

    Time frame: 4-6 weeks, 6 months, and 12 months

  5. Tobacco Use

    Tobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use.

    Time frame: 4-6 weeks, 6 months, and 12 months

  6. Cannabis Use

    Cannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis.

    Time frame: 4-6 weeks, 6 months, and 12 months

  7. Total Problems (adolescent report)

    The Youth Self Report (YSR) is the self-report adolescent version of the Child Behavior Checklist, and is used to assess emotional and behavioral problems in children and adolescents.

    Time frame: 4-6 weeks, 6 months, 12 months

  8. Mindfulness

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness

    Time frame: 4-6 weeks, 6 months, and 12 months

  9. Anxiety and Depression

    Pre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains.

    Time frame: 4-6 weeks, 6 months, and 12 months

  10. Perceived Tolerance of Use

    The Perceived Tolerance of Use is a tool that assesses peer tolerance of use of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is a tool that is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use.

    Time frame: baseline

  11. Perceived Harm of Substance Use

    The Perceived Harm of Substance Use tool assesses perceived harm of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use.

    Time frame: baseline

  12. Beliefs About Alcohol Effects

    The Brief Comprehensive Effects of Alcohol Questionnaire is a 15-item self-report version of the Comprehensive Effects of Alcohol Questionnaire that is used by the ABCD study to assess an adolescent's expectations of using alcohol.

    Time frame: baseline

  13. Beliefs About Smoking Effects

    The Adolescent Smoking Consequences Questionnaire (ASCQ) is a 30-item self-report instrument used to assess outcome expectancies of cigarette smoking among adolescents.

    Time frame: baseline

  14. Beliefs About Cannabis Effects

    Brief -Marijuana Effect Expectancies Questionnaire (MEEQ-B) is a 6-item self-report assessment of an adolescent's expected effect of marijuana.

    Time frame: baseline

  15. Risk and Protective Factors

    The Community Risk and Protective Factors Survey is a 24-item parent-report tool to assess adolescent's experience of exposure to substance use risk and protective factors in the community.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jan 2028, 15 months later.

Of 814 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 15 months is below that.

Counting every sponsor, half of 854 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2024
First posted
Sep 19, 2024
StartEst.
Oct 1, 2026
Primary completionEst.
Jan 1, 2028
CompletionEst.
Jan 1, 2028
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
45→40
Sep 25, 2026
Eligibility
2 inclusion criteria edited; 1 exclusion criterion edited, 2 removed
What changed in the criteria
Inclusion criteria
  • EditedAccessYouth has access to a smart phonesmartphone, tablet, or computer with Wi-Fi
  • EditedYouth and parent are English-speaking
Exclusion criteria
  • EditedHas1. The youth has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
  • RemovedYouth is actively involved in another Boricua Youth Study (BYS)
  • RemovedYouth's sibling is or has previously been enrolled in MINDS-UP.
Sep 25, 2026
Interventions
Removed Diagnostic test: fMRI. Arms added: PPW + MINDS-UP; arms removed: MINDS-UP with MRI + PPW·MINDS-UP without MRI + PPW
Sep 25, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Participation (student)Now Student-Rated ParticipationTime frame: Completion of Study (up to 36 months)
Sep 25, 2026
Secondary outcomes
1 edited, 1 time frame changed, 7 added, 4 removed, 1 description edited
What changed in the outcomes
  • EditedExternalizingTotal Problems (parent-adolescent report)Time frame: 4-6 weeks, 6 months, and 12 months → 4-6 weeks, 6 months, 12 months
  • AddedSuicidal Thoughts/BehaviorsTime frame: 4-6 weeks, 6 months, 12 months
  • AddedPerceived Tolerance of UseTime frame: baseline
  • AddedPerceived Harm of Substance UseTime frame: baseline
  • AddedBeliefs About Alcohol EffectsTime frame: baseline
  • AddedBeliefs About Smoking EffectsTime frame: baseline
  • AddedBeliefs About Cannabis EffectsTime frame: baseline
  • AddedRisk and Protective FactorsTime frame: Baseline
  • RemovedMRI retentionTime frame: Completion of Study (up to 36 months)
  • RemovedFuture MRI endorsementTime frame: Completion of Study (up to 36 months)
  • RemovedExternalizing Problems (self-report)Time frame: 4-6 weeks, 6 months, and 12 months
  • RemovedTotal Problems (self-report)Time frame: 4-6 weeks, 6 months, and 12 months
  • Time frameTotal Problems (parent-report)4-6 weeks, 6 months, and 12 months → 4-8 weeks, 6 months, and 12 months
  • DescriptionADHD Symptoms: how it is measured was reworded
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Enrollment 45→40
    Eligibility 2 inclusion criteria edited; 1 exclusion criterion edited, 2 removed
    What changed in the criteria
    Inclusion criteria
    • EditedAccessYouth has access to a smart phonesmartphone, tablet, or computer with Wi-Fi
    • EditedYouth and parent are English-speaking
    Exclusion criteria
    • EditedHas1. The youth has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
    • RemovedYouth is actively involved in another Boricua Youth Study (BYS)
    • RemovedYouth's sibling is or has previously been enrolled in MINDS-UP.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Participation (student)Now Student-Rated ParticipationTime frame: Completion of Study (up to 36 months)
    Secondary outcomes 1 edited, 1 time frame changed, 7 added, 4 removed, 1 description edited
    What changed in the outcomes
    • EditedExternalizingTotal Problems (parent-adolescent report)Time frame: 4-6 weeks, 6 months, and 12 months → 4-6 weeks, 6 months, 12 months
    • AddedSuicidal Thoughts/BehaviorsTime frame: 4-6 weeks, 6 months, 12 months
    • AddedPerceived Tolerance of UseTime frame: baseline
    • AddedPerceived Harm of Substance UseTime frame: baseline
    • AddedBeliefs About Alcohol EffectsTime frame: baseline
    • AddedBeliefs About Smoking EffectsTime frame: baseline
    • AddedBeliefs About Cannabis EffectsTime frame: baseline
    • AddedRisk and Protective FactorsTime frame: Baseline
    • RemovedMRI retentionTime frame: Completion of Study (up to 36 months)
    • RemovedFuture MRI endorsementTime frame: Completion of Study (up to 36 months)
    • RemovedExternalizing Problems (self-report)Time frame: 4-6 weeks, 6 months, and 12 months
    • RemovedTotal Problems (self-report)Time frame: 4-6 weeks, 6 months, and 12 months
    • Time frameTotal Problems (parent-report)4-6 weeks, 6 months, and 12 months → 4-8 weeks, 6 months, and 12 months
    • DescriptionADHD Symptoms: how it is measured was reworded
    Interventions Removed Diagnostic test: fMRI. Arms added: PPW + MINDS-UP; arms removed: MINDS-UP with MRI + PPW·MINDS-UP without MRI + PPW
    + 3 other changes: verification date, description and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06593470
Responsible party
David Saunders, MD PhD (Assistant Prof of Psychiatry, New York State Psychiatric Institute) — Principal investigator
First posted
Sep 19, 2024
Start date
Oct 1, 2026 (estimated)
Primary completion
Jan 1, 2028 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Sep 25, 2026

Study contacts

David C Saunders, MD, PhD
Contact
david.saunders@nyspi.columbia.edu
914-409-6807

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion